Lataa...
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
Recent international epidemics of coronavirus-associated illnesses underscore the urgent medical and public health need for vaccine development and regulatory body approved therapies. In particular, the current coronavirus disease 2019 (COVID-19) pandemic has quickly intensified interest in developi...
Tallennettuna:
| Julkaisussa: | One Health |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7118644/ https://ncbi.nlm.nih.gov/pubmed/32258351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.onehlt.2020.100128 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|